Abstract
|
Evaluation of Ischemia-Modified Albumin in Patients with Inflammatory Bowel Disease
by Gulcan Guntas, Abdurrahman Sahin, Sermin Duran, Resul Kahraman, Ilyas Duran, Cigdem Sonmez, Turhan Calhan, Haci Mehmet Sokmen
|
|
|
Background: Inflammatory bowel disease (IBD) is considered a chronic gastrointestinal inflammatory disease with unknown etiology. Oxidative stress has been demonstrated to play a critical role in the pathophysiology of IBD. We aimed to investigate the effect of the ischemia-modified albumin (IMA) and CRP levels on the pathophysiology and activities of IBD and its subgroups.
Methods: The study included 39 patients with Crohn’s disease (CD) and 41 patients with ulcerative colitis (UC). Thirty-three healthy volunteers participated in the study as the control group. The IMA concentrations were determined by colorimetric method.
Results: IMA levels were significantly higher in IBD than in the controls (p = 0.02). In the subgroups of IBD, IMA levels were significantly lower in the control group and CD group than in UC (p < 0.001 and p < 0.001, respectively) while IMA levels were significant higher in the UC when compared with the CD group (p < 0.001). C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) levels were significantly higher in the CD group compared to the control group (p < 0.01 and p < 0.02, respectively).
Conclusions: Higher IMA level, which is a marker of oxidative stress in diseases with inflammation, indicates that inflammation and oxidative stress are related in the pathogenesis of IBD.
DOI: 10.7754/Clin.Lab.2016.160623
|
